CAMBRIDGE, Mass. & SINGAPORE--(BUSINESS WIRE)--April 21, 2006--CombinatoRx (Singapore) Pte. Ltd., a subsidiary of CombinatoRx, Incorporated (NASDAQ: CRXX - News), has received approval for a grant from the Economic Development Board of Singapore (EDB) Biomedical Sciences Group to support infectious disease drug research and development. The Research Incentive Scheme for Companies (RISC) grant is intended to encourage the development of strategic technologies and capabilities in Singapore. CombinatoRx Singapore plans to use this grant to discover and potentially develop novel product candidates to treat infectious diseases.
